News

Article

Eye surgery showcase goes to Australian Parliament House

Author(s):

Key Takeaways

  • The ASO Eye Surgery Showcase highlighted the collaboration between ophthalmologists and medical technology innovators to prevent blindness in Australia.
  • Nearly 50% of Australians have long-term eye conditions, with 90% of blindness cases being preventable, underscoring the need for improved eye care.
SHOW MORE

The Australian Society of Ophthalmologists hosted its inaugural Eye Surgery Showcase, where participants learned how ophthalmologists and the medical technology industry are working together to save the sight of Australians.

(Image credit: Adobe Stock/K.Mongkol)

(Image credit: Adobe Stock/K.Mongkol)

The Australian Society of Ophthalmologists (ASO) hosted its inaugural Eye Surgery Showcase at Australian Parliament House.

According to an ASO news release, eye surgeons and medical technology innovators took the “operating theatre” to Australian Parliament House (APH) for politicians and healthcare policymakers this National Science Week.

Participants learned how ophthalmologists and the medical technology industry are working together to save the sight of Australians. The event was opened and closed by the Co-Chairs of the Parliamentary Friends of Eye Health Group, Hon Dr David Gillespie MP and Meryl Swanson MP.

Alcon, Device Technologies, Glaukos, Johnson and Johnson, and ZEISS brought the technology as local Canberra ophthalmologists guided politicians and healthcare policymakers as they ‘tried their hand’ at complex eye surgery.

ASO CEO Kerry Gallagher AM, said ophthalmologists are leaders in addressing eye health diseases and conditions through surgical intervention, that often without, rob us of our sight and quality of life.

“Close to one in two Australians have one or more long-term eye conditions that impact upon the quality of their day-to-day life,” Gallagher said. “A further 9 in 10 of us say that sight is our most valued sense, yet a remarkable 90 per cent of all cases of blindness in Australia are preventable.”

ASO President Dr Peter Sumich said the rate of unaddressed and treatable blindness will continue to increase in Australia if something does not change.

“By bringing global leaders in medical technology and local Canberra-based eye surgeons together at Australian Parliament House, we are taking a ‘hands on’, ‘experience it yourself’ approach to educating our elected representatives and healthcare policymakers on what is at stake,” Sumich said. “Australian eye surgeons and our medical technology industry are among the best in the world, yet our community eye health statistics are alarming for a first-world country.”

The ASO said it is aiming to increase understanding of the prevalence and surgical treatment of eye disease, awareness of the critical role of ophthalmologist in access to world-class eye health technology and surgical treatments, and appreciation of the innovative surgical technologies used in the prevention of blindness in Australia.”

“If we can achieve this, we can work collaboratively with government on strategies and principles for the delivery of eye services to rural, remote, and Indigenous communities as well as improved access within the public sector to ophthalmology services,” Sumich said in the ASO news release.

Currently in Australia, a majority of ophthalmology services are delivered through the private health sector.

The ASO Eye Surgery Showcase is an officially recognised National Science Week 2024 Inspiring Australia event, an initiative of the Australian Government. 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
(Image credit: Ophthalmology Times) CCOI's new CEO Malvina Eydelman, MD, outlines her mission and vision for the organization
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
© 2025 MJH Life Sciences

All rights reserved.